黄芪联合牛磺酸治疗病毒性心肌炎临床观察  

Clinical Observation of Astragalus Combined with Taurine in Treatment of Viral Myocarditis

作　　者：刘乾坤 曾艳辉[2] 于小华[3] 李双杰[3] 

机构地区：[1]武警广东总队韶关市支队卫生队,广东韶关512000 [2]南华大学附一医院心内科 [3]南华大学附一儿科,421001

出　　处：《现代生物医学进展》2007年第1期74-75,共2页Progress in Modern Biomedicine

基　　金：国家自然科学基金(NO:30271665)

摘　　要：目的:探讨黄芪联合牛磺酸治疗病毒性心肌炎的临床疗效。方法:80例病毒性心肌炎患儿随机分成对照组和治疗组各40例,对照组予常规治疗,治疗组在此治疗基础上加用黄芪注射液和牛磺酸,进行临床疗效比较。结果:治疗组主要症状及体征改善情况明显优于对照组,治疗组治疗后血清肌酸磷酸激酶(CPK)、天冬氨酸转氨酶(AST)及血清乳酸脱氢酶(LDH)较治疗前明显降低(P＜0．05),而对照组CPK、AST、LDH治疗前后比较差异均无显著性(P＞0．05),治疗组总有效率明显高于对照组,差异有显著性(P＜0．05)。结论:黄芪联合牛磺酸对病毒性心肌炎具有明显的治疗作用。Objective： To investigate the clinical effect of Astragalus combined with taurine on viral myocarditis （VM）, Methods： 80 children patients with VM were randomly divided into the control group （n=40） and the treatment group （n=40）. Control group was given common treatment. Treatment group was given Astragalus combined with taurine based on common treatment. Clinical effects were compared. Results： The main symptoms and signs were alleviated obviously in treatment group compared with control group. GPK, AST and LDH in treatment group markedly decreased after treatment （P〈0.05）, but there was no significant change in control group （P〉0.05）. The gross effective rate was higher in treatment group than that in control group. Conclusion： Astragalus combined with taurine is more effective in treating viral myocarditis.

关 键 词：病毒性心肌炎 黄芪 牛磺酸 

分 类 号：R542.2[医药卫生—心血管疾病]